References
- Mandel L, Tharakan M. Treatment of unilateral masseteric hypertrophy with botulinum toxin: case report. J Oral Maxillofac Surg. 1999;57:1017–1019.
- Addante RR. Masseter muscle hypertrophy: report of case and literature review. J Oral Maxillofac Surg. 1994;52: 1199–1202.
- Ham JW. Masseter muscle reduction procedure with radiofrequency coagulation. J Oral Maxillofac Surg. 2009;67: 457–463.
- Smyth AG. Botulinum toxin treatment of bilateral masseteric hypertrophy. Br J Oral Maxillofac Surg. 1994;32:29–33.
- Moore AP, Wood GD. The medical management of masseteric hypertrophy with botulinum toxin type A. Br J Oral Maxillofac Surg. 1994;32:26–28.
- Maestre-Ferrín L, Burguera JA, Peñarrocha-Diago M, Peñarrocha-Diago M. Oromandibular dystonia: a dental approach. Med Oral Patol Oral Cir Bucal. 2009;15:e25–27.
- Martos Díaz P, Bances del Castillo R, Mancha de la Plata M, Naval Gías L, Martínez Nieto C, Lee GY, Muñoz Guerra M. Clinical results in the management of Frey's syndrome with injections of Botulinum toxin. Med Oral Patol Oral Cir Bucal. 2008;13:E248–252.
- Keaney TC, Alster TS. Botulinum toxin in men: review of relevant anatomy and clinical trial data. Dermatol Surg. 2013; 39:1434–1443.